Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.16)
# 1,536
Out of 4,614 analysts
426
Total ratings
28.68%
Success rate
-13.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $1.63 | +329.45% | 5 | Oct 3, 2024 | |
| ELVN Enliven Therapeutics | Reiterates: Buy | $37 | $27.53 | +34.40% | 2 | Oct 1, 2024 | |
| ZYME Zymeworks | Maintains: Neutral | $10 → $12 | $12.57 | -4.53% | 16 | Sep 25, 2024 | |
| BDTX Black Diamond Therapeutics | Reiterates: Buy | $11 | $3.75 | +193.33% | 10 | Sep 24, 2024 | |
| RPTX Repare Therapeutics | Reiterates: Buy | $10 | $3.75 | +166.67% | 15 | Sep 23, 2024 | |
| PRLD Prelude Therapeutics | Upgrades: Buy | $5 | $2.00 | +150.00% | 12 | Sep 19, 2024 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $21 | $9.61 | +118.52% | 16 | Sep 18, 2024 | |
| MGNX MacroGenics | Reiterates: Neutral | $4 | $3.59 | +11.42% | 19 | Sep 18, 2024 | |
| EXEL Exelixis | Reiterates: Buy | $29 | $26.66 | +8.78% | 3 | Sep 18, 2024 | |
| BNTX BioNTech SE | Reiterates: Buy | $113 | $122.68 | -7.89% | 35 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $6.53 | +190.96% | 16 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.41 | +190.46% | 11 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $11.56 | +47.06% | 12 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $27.26 | +32.06% | 5 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $6.98 | +86.25% | 9 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $15.41 | -28.62% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.87 | +381.28% | 11 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $11.11 | +53.02% | 7 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $76 | $32.64 | +132.84% | 27 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.60 | +117.39% | 6 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.94 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.69 | - | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.53 | +226.80% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.99 | +126.63% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.12 | +971.43% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.70 | +233.33% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $14.16 | +55.37% | 16 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $17.77 | +85.71% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $47.32 | +18.34% | 16 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.29 | +143.16% | 18 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $26 | $22.20 | +17.12% | 11 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.16 | +1,165.82% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.23 | +1,616.74% | 8 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $1.06 | +1,786.79% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.51 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.02 | +7,325.74% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.70 | +1,194.12% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $3.22 | +117.39% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $1.15 | +856.52% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $1.98 | +11,263.64% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $5.02 | +398.01% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $3.98 | +226.63% | 1 | Jan 7, 2021 |
Immix Biopharma
Oct 3, 2024
Reiterates: Buy
Price Target: $7
Current: $1.63
Upside: +329.45%
Enliven Therapeutics
Oct 1, 2024
Reiterates: Buy
Price Target: $37
Current: $27.53
Upside: +34.40%
Zymeworks
Sep 25, 2024
Maintains: Neutral
Price Target: $10 → $12
Current: $12.57
Upside: -4.53%
Black Diamond Therapeutics
Sep 24, 2024
Reiterates: Buy
Price Target: $11
Current: $3.75
Upside: +193.33%
Repare Therapeutics
Sep 23, 2024
Reiterates: Buy
Price Target: $10
Current: $3.75
Upside: +166.67%
Prelude Therapeutics
Sep 19, 2024
Upgrades: Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
ORIC Pharmaceuticals
Sep 18, 2024
Reiterates: Buy
Price Target: $21
Current: $9.61
Upside: +118.52%
MacroGenics
Sep 18, 2024
Reiterates: Neutral
Price Target: $4
Current: $3.59
Upside: +11.42%
Exelixis
Sep 18, 2024
Reiterates: Buy
Price Target: $29
Current: $26.66
Upside: +8.78%
BioNTech SE
Sep 16, 2024
Reiterates: Buy
Price Target: $113
Current: $122.68
Upside: -7.89%
Sep 16, 2024
Maintains: Buy
Price Target: $18 → $19
Current: $6.53
Upside: +190.96%
Sep 16, 2024
Maintains: Buy
Price Target: $8 → $7
Current: $2.41
Upside: +190.46%
Sep 16, 2024
Reiterates: Buy
Price Target: $17
Current: $11.56
Upside: +47.06%
Sep 10, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $27.26
Upside: +32.06%
Sep 10, 2024
Reiterates: Buy
Price Target: $13
Current: $6.98
Upside: +86.25%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $15.41
Upside: -28.62%
Sep 3, 2024
Reiterates: Buy
Price Target: $9
Current: $1.87
Upside: +381.28%
Sep 3, 2024
Maintains: Buy
Price Target: $19 → $17
Current: $11.11
Upside: +53.02%
Aug 28, 2024
Reiterates: Buy
Price Target: $76
Current: $32.64
Upside: +132.84%
Aug 23, 2024
Reiterates: Buy
Price Target: $10
Current: $4.60
Upside: +117.39%
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.94
Upside: -
Aug 21, 2024
Reiterates: Neutral
Price Target: n/a
Current: $7.69
Upside: -
Aug 20, 2024
Reiterates: Buy
Price Target: $5
Current: $1.53
Upside: +226.80%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.99
Upside: +126.63%
Aug 15, 2024
Reiterates: Buy
Price Target: $12
Current: $1.12
Upside: +971.43%
Aug 15, 2024
Reiterates: Buy
Price Target: $9
Current: $2.70
Upside: +233.33%
Aug 13, 2024
Reiterates: Buy
Price Target: $22
Current: $14.16
Upside: +55.37%
Aug 13, 2024
Reiterates: Buy
Price Target: $33
Current: $17.77
Upside: +85.71%
Aug 12, 2024
Reiterates: Buy
Price Target: $56
Current: $47.32
Upside: +18.34%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $3.29
Upside: +143.16%
Jun 18, 2024
Maintains: Buy
Price Target: $19 → $26
Current: $22.20
Upside: +17.12%
May 8, 2024
Maintains: Buy
Price Target: $5 → $2
Current: $0.16
Upside: +1,165.82%
Apr 16, 2024
Reiterates: Buy
Price Target: $4
Current: $0.23
Upside: +1,616.74%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $1.06
Upside: +1,786.79%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.51
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.02
Upside: +7,325.74%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.70
Upside: +1,194.12%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $3.22
Upside: +117.39%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $1.15
Upside: +856.52%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $1.98
Upside: +11,263.64%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $5.02
Upside: +398.01%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $3.98
Upside: +226.63%